نتایج جستجو برای: cd95l

تعداد نتایج: 278  

Journal: :Journal of the National Cancer Institute 1997
K M Debatin

Since the first use of aminopterin to treat childhood leukemia by Sidney Farber almost 50 years ago, chemotherapy for leukemias and solid tumors has come a long way (1). With combinations of several drugs in the 1960s and early 1970s and the development of repetitive cycle protocols, long-term remission of some cancers has been achieved in a considerable number of patients. Dose-intensification...

Journal: :International immunology 1998
A D Wilson I Redchenko N A Williams A J Morgan

Greater than 90% of the human population acquire Epstein-Barr virus (EBV) in infancy and retain a lifelong latent infection without any clinical consequences. Nevertheless EBV has been identified as the causal agent of infectious mononucleosis, and is associated with several tumours including endemic Burkitt's lymphoma and B cell lymphomas in immunosupressed patients. B cells infected with EBV ...

Journal: :Infection and immunity 2001
M Takahashi M Takahashi F Shinohara H Takada H Rikiishi

To investigate the mechanisms underlying superantigen (SAg) stimulation, we analyzed the effect of SAg on monocyte responses with or without lipopolysaccharide (LPS). Addition of gamma interferon (IFN-gamma) to unstimulated cultures induced a marked increase in the number of CD80(+) monocytes, which was inhibited by LPS through the action of interleukin-10. However, CD80(+) monocytes began to i...

Journal: :Advances in experimental medicine and biology 1997
L Lu S Qian T E Starzl D H Lynch A W Thomson

Dendritic cells (DC) are antigen presenting cells of hemopoietic origin, uniquely well-equipped to activate naive T cells. 1 Evidence also exists however, for DC tolerogenicity.2 During primary activation, mature T cells change from an activation-induced cell death (AICD) -resistant to an AICD-sensitive phenotype.3 The complete molecular basis for this transition remains to be determined, but C...

Journal: :Journal of immunology 1998
W Böhm S Thoma F Leithäuser P Möller R Schirmbeck J Reimann

The murine melanoma cell line B16.F10 (H-2b) was used to study specific T cell responses that reject tumors. Stable B16 transfectants were established that express viral Ags, either the hepatitis B surface Ag (HBsAg) or the large tumor Ag (T-Ag) of SV40. B16 cells and their transfected sublines were CD40+ CD44+ but expressed no (or low levels of the) costimulator molecules CD154 (CD40L), CD48, ...

Journal: :Blood 2007
Consuelo Gajate Faustino Mollinedo

Multiple myeloma (MM) is an incurable B-cell malignancy, requiring new therapeutic strategies. We have found that synthetic alkyl-lysophospholipids (ALPs) edelfosine and perifosine induced apoptosis in MM cell lines and patient MM cells, whereas normal B and T lymphocytes were spared. ALPs induced recruitment of Fas/CD95 death receptor, Fas-associated death domain-containing protein, and procas...

Journal: :Journal of immunology 2000
D Rosen J H Li S Keidar I Markon R Orda G Berke

CTL and NK cells use two distinct cytocidal pathways: 1) perforin and granzyme based and 2) CD95L/CD95 mediated. The former requires perforin expression by the effectors (CTL or NK), whereas the latter requires CD95 (Fas/APO-1) expression by the target. We have investigated how these two factors contribute to tumor immune surveillance by studying the immunity of perforin-deficient mice against ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید